Contract 75A50124C00032
Ossium Health, Inc. · Department Of Health And Human Services · August 8, 2024
Ossium Health, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 8, 2024 for $33.44 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in San Francisco, CA. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost sharing contract pricing. The most recent modification was on March 3, 2026. If all options are exercised, the contract could reach $110.47 million.
Contract details
- PIID
- 75A50124C00032
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care - Other; Applied Research
- Place of performance
- San Francisco, CA
- First action
- August 8, 2024
- Latest action
- March 3, 2026
Description
BONE MARROW CRYO-BANKING TO TREAT ACUTE RADIATION SYNDROME IN A MASS-CASUALTY EMERGENCY
Modification timeline
-
March 3, 2026Mod P00002 · Exercise An Option$33.44M
-
August 9, 2024Mod P00001 · Other Administrative Action$21.04M
-
August 8, 2024Base award$21.04M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00032?
Contract 75A50124C00032 is a federal contract awarded to Ossium Health, Inc. by Department Of Health And Human Services on August 8, 2024 for $33.44 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75A50124C00032?
Ossium Health, Inc. won contract 75A50124C00032 from Department Of Health And Human Services.
How much is contract 75A50124C00032 worth?
Contract 75A50124C00032 has obligated $33.44 million to date, with a total potential value of $110.47 million if all options are exercised.